Literature DB >> 31682167

A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa.

Karl W Le Roux1,2, Emily C Davis3, Charles Benjamin Gaunt1, Catherine Young4, Maryann Koussa3, Carl Harris5, Mary Jane Rotheram-Borus3.   

Abstract

The delivery of high-quality HIV care in rural settings is a global challenge. Despite the successful expansion of antiretroviral therapy (ART) in Africa, viral load (VL) monitoring and ART adherence are poor, especially in rural communities. This article describes a case study of an ART program in the deeply rural Eastern Cape of South Africa. The Zithulele ART Program initiated five innovations over time: (1) establishing district hospital as the logistical hub for all ART care in a rural district, (2) primary care clinic delivery of prepackaged ART and chronic medications for people living with HIV (PLH), (3) establishing central record keeping, (4) incentivizing VL monitoring, and (5) providing hospital-based outpatient care for complex cases. Using a pharmacy database, on-time VL monitoring and viral suppression were evaluated for 882 PLH initiating ART in the Zithulele catchment area in 2013. Among PLH initiating ART, 12.5% (n = 110) were lost to follow-up, 7.7% (n = 68) transferred out of the region, 10.2% (n = 90) left the program and came back at a later date, and 4.0% (n = 35) died. Of the on-treatment population, 82.9% (n = 480/579) had VL testing within 7 months and 92.6% (n = 536/579) by 1 year. Viral suppression was achieved in 85.2% of those tested (n = 457/536), or 78.9% (n = 457/579) overall. The program's VL testing and suppression rates appear about twice as high as national data and data from other rural centers in South Africa, despite fewer resources than other programs. Simple system innovations can ensure high rates of VL testing and suppression, even in rural health facilities.

Entities:  

Keywords:  HIV; South Africa; antiretroviral therapy; prepackaging ART; rural health care; viral load monitoring; viral suppression

Mesh:

Substances:

Year:  2019        PMID: 31682167      PMCID: PMC6839417          DOI: 10.1089/apc.2019.0055

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  27 in total

1.  Rural district hospitals - essential cogs in the district health system - and primary healthcare re-engineering.

Authors:  K W D P le Roux; I Couper
Journal:  S Afr Med J       Date:  2015-06

2.  The household costs of health care in rural South Africa with free public primary care and hospital exemptions for the poor.

Authors:  Jane Goudge; Lucy Gilson; Steve Russell; Tebogo Gumede; Anne Mills
Journal:  Trop Med Int Health       Date:  2009-02-22       Impact factor: 2.622

3.  Drug stock-outs: inept supply-chain management and corruption.

Authors:  Chris Bateman
Journal:  S Afr Med J       Date:  2013-09

4.  HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.

Authors:  T M Rossouw; M Nieuwoudt; J Manasa; G Malherbe; R J Lessells; S Pillay; S Danaviah; P Mahasha; G van Dyk; T de Oliveira
Journal:  HIV Med       Date:  2016-06-28       Impact factor: 3.180

Review 5.  Understanding shortages of sufficient health care in rural areas.

Authors:  Ines Weinhold; Sebastian Gurtner
Journal:  Health Policy       Date:  2014-08-14       Impact factor: 2.980

Review 6.  A meta-analysis of effectiveness of interventions to improve adherence in pregnant women receiving antiretroviral therapy in sub-Saharan Africa.

Authors:  Olumuyiwa Omonaiye; Pat Nicholson; Snezana Kusljic; Elizabeth Manias
Journal:  Int J Infect Dis       Date:  2018-07-09       Impact factor: 3.623

7.  Community-supported models of care for people on HIV treatment in sub-Saharan Africa.

Authors:  Marielle Bemelmans; Saar Baert; Eric Goemaere; Lynne Wilkinson; Martin Vandendyck; Gilles van Cutsem; Carlota Silva; Sharon Perry; Elisabeth Szumilin; Rodd Gerstenhaber; Lucien Kalenga; Marc Biot; Nathan Ford
Journal:  Trop Med Int Health       Date:  2014-05-28       Impact factor: 2.622

8.  Time and Money: The True Costs of Health Care Utilization for Patients Receiving "Free" HIV/Tuberculosis Care and Treatment in Rural KwaZulu-Natal.

Authors:  Natsayi Chimbindi; Jacob Bor; Marie-Louise Newell; Frank Tanser; Rob Baltussen; Jan Hontelez; Sake J de Vlas; Mark Lurie; Deenan Pillay; Till Bärnighausen
Journal:  J Acquir Immune Defic Syndr       Date:  2015-10-01       Impact factor: 3.771

9.  Treatment outcomes in a rural HIV clinic in South Africa: Implications for health care.

Authors:  Olufemi B Omole; Mary-Anne M L Semenya
Journal:  South Afr J HIV Med       Date:  2016-05-27       Impact factor: 2.744

10.  Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.

Authors:  Hannock Tweya; Caryl Feldacker; Janne Estill; Andreas Jahn; Wingston Ng'ambi; Anne Ben-Smith; Olivia Keiser; Mphatso Bokosi; Matthias Egger; Colin Speight; Joe Gumulira; Sam Phiri
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

View more
  3 in total

1.  Quality of antiretroviral therapy services in Ghana: Implications for the HIV response in resource-constrained settings.

Authors:  Robert Kaba Alhassan; Courage Edem Ketor; Anthony Ashinyo; Mary Eyram Ashinyo; Jerry John Nutor; Conrad Adjadeh; Emmanuel Sarkodie
Journal:  SAGE Open Med       Date:  2021-07-31

2.  Implementation of South Africa's Central Chronic Medicine Dispensing and Distribution Program for HIV Treatment: A Qualitative Evaluation.

Authors:  Laura M Bogart; Zinhle Shazi; Sarah MacCarthy; Alexandra Mendoza-Graf; Nafisa J Wara; Dani Zionts; Nduduzo Dube; Sabina Govere; Ingrid V Bassett
Journal:  AIDS Behav       Date:  2022-02-04

3.  Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead - a systematic review.

Authors:  Minh D Pham; Huy V Nguyen; David Anderson; Suzanne Crowe; Stanley Luchters
Journal:  BMC Public Health       Date:  2022-06-16       Impact factor: 4.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.